{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:19:18Z","timestamp":1792343958720,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.psychres.2023.115585","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T11:36:14Z","timestamp":1698665774000},"page":"115585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol"],"prefix":"10.1016","volume":"330","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0395-710X","authenticated-orcid":false,"given":"Brandon M.","family":"Kitay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Macaluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Corlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5471-6694","authenticated-orcid":false,"given":"Rachel","family":"Hershenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Joormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8343-504X","authenticated-orcid":false,"given":"Valeria","family":"Martinez-Kaigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9024-038X","authenticated-orcid":false,"given":"Sina","family":"Nikayin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-3361","authenticated-orcid":false,"given":"Taeho Greg","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-8829","authenticated-orcid":false,"given":"Gerard","family":"Sanacora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3806-4208","authenticated-orcid":false,"given":"Richard C.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Thase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2023.115585_bib0001","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11920-015-0614-9","article-title":"Psychopharmacological agents and suicide risk reduction: ketamine and other approaches","volume":"17","author":"Al Jurdi","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psychres.2023.115585_bib0002","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/509421a","article-title":"Mental health: a road map for suicide research and prevention","volume":"509","author":"Aleman","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2023.115585_bib0003","unstructured":"Allison, P., 2010. Survival analysis using SAS: a practical guide."},{"key":"10.1016\/j.psychres.2023.115585_bib0004","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jamapsychiatry.2022.0696","article-title":"Efficacy of augmentation of cognitive behavioral therapy with transcranial direct current stimulation for depression: a randomized clinical trial","volume":"79","author":"Aust","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0006","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biopsych.2013.11.030","article-title":"Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial","volume":"76","author":"Brakemeier","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0007","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/jama.294.5.563","article-title":"Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial","volume":"294","author":"Brown","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2023.115585_bib0008","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","article-title":"Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study","volume":"175","author":"Canuso","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0009","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4088\/JCP.08m04927blu","article-title":"Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials","volume":"72","author":"Carpenter","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1017\/S0033291702006943","article-title":"Psychological autopsy studies of suicide: a systematic review","volume":"33","author":"Cavanagh","year":"2003","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2023.115585_bib0011","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jamapsychiatry.2017.1044","article-title":"Suicide rates after discharge from psychiatric facilities: a systematic review and meta-analysis","volume":"74","author":"Chung","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0012","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1176\/ajp.153.8.1001","article-title":"Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study","volume":"153","author":"Conwell","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0013","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10488-014-0618-5","article-title":"Beyond the label: relationship between community therapists' self-report of a cognitive behavioral therapy orientation and observed skills","volume":"43","author":"Creed","year":"2016","journal-title":"Adm. Policy Ment. Health"},{"key":"10.1016\/j.psychres.2023.115585_bib0014","unstructured":"Curtin, S.C., Warner, M., Hedegaard, H., 2016. Increase in Suicide in the United States, 1999-2014. NCHS Data Brief, 1\u20138."},{"key":"10.1016\/j.psychres.2023.115585_bib0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of Esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0016","doi-asserted-by":"crossref","unstructured":"Domany, Y., Shelton, R.C., McCullumsmith, C.B., 2019. Ketamine for acute suicidal ideation. An emergency department intervention: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Depress Anxiety.","DOI":"10.2139\/ssrn.3367057"},{"key":"10.1016\/j.psychres.2023.115585_bib0017","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13191","article-title":"Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I)","volume":"81","author":"Fu","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0018","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archgenpsychiatry.2011.2048","article-title":"Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine","volume":"69","author":"Gibbons","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0019","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.amepre.2014.06.012","article-title":"Existing and novel biological therapeutics in suicide prevention","volume":"47","author":"Griffiths","year":"2014","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.psychres.2023.115585_bib0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bdi.12487","article-title":"Ketamine versus midazolam in bipolar depression with suicidal thoughts: a pilot midazolam-controlled randomized clinical trial","volume":"19","author":"Grunebaum","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.psychres.2023.115585_bib0021","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0022","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0023","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archpsyc.62.4.417","article-title":"Prevention of relapse following cognitive therapy vs medications in moderate to severe depression","volume":"62","author":"Hollon","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0024","article-title":"Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized study (ASPIRE II)","author":"Ionescu","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2023.115585_bib0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ijnp\/pyaa068","article-title":"Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)","volume":"24","author":"Ionescu","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2023.115585_bib0026","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jama.292.3.338","article-title":"Antidepressants and the risk of suicidal behaviors","volume":"292","author":"Jick","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2023.115585_bib0027","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.psychres.2023.115585_bib0028","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0029","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2023.115585_bib0030","article-title":"Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response","author":"Murrough","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2023.115585_bib0031","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000096363","article-title":"Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes","volume":"76","author":"Perlis","year":"2007","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.psychres.2023.115585_bib0032","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1176\/appi.ajp.20220216","article-title":"A novel, brief, fully automated intervention to extend the antidepressant effect of a single ketamine infusion: a randomized clinical trial","volume":"179","author":"Price","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0033","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.2014.14070843","article-title":"Brief cognitive-behavioral therapy effects on post-treatment suicide attempts in a military sample: results of a randomized clinical trial with 2-year follow-up","volume":"172","author":"Rudd","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0034","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1017\/S1461145714001011","article-title":"Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression","volume":"17","author":"Shiroma","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2023.115585_bib0035","article-title":"Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials","volume":"19","author":"Sim","year":"2015","journal-title":"Int. J. neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2023.115585_bib0036","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1176\/appi.ajp.2017.17010089","article-title":"Improving the efficiency of psychotherapy for depression: computer-assisted versus standard CBT","volume":"175","author":"Thase","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0037","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12891","article-title":"Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2)","volume":"81","author":"Wajs","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0038","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0039","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.biopsych.2018.09.004","article-title":"Leveraging neuroplasticity to enhance adaptive learning: the potential for synergistic somatic-behavioral treatment combinations to improve clinical outcomes in depression","volume":"85","author":"Wilkinson","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517074","article-title":"Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: a randomized clinical trial","volume":"90","author":"Wilkinson","year":"2021","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.psychres.2023.115585_bib0041","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000457960","article-title":"Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression","volume":"86","author":"Wilkinson","year":"2017","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.psychres.2023.115585_bib0042","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1176\/appi.ajp.162.6.1158","article-title":"Computer-assisted cognitive therapy for depression: maintaining efficacy while reducing therapist time","volume":"162","author":"Wright","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0043","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115585_bib0044","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6904a3","article-title":"Syndromic surveillance of suicidal ideation and self-directed violence - United States, January 2017-December 2018","volume":"69","author":"Zwald","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123005358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123005358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:01:47Z","timestamp":1759039307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178123005358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":44,"alternative-id":["S0165178123005358"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115585","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115585"}}